A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients

BACKGROUND: Currently available treatment options for chronic hepatitis B (CHB) are not recommended for HBeAg-negative patients with a low viral load. These patients may however benefit from treatment by achieving a functional cure, defined by HBsAg-loss and undetectable HBV DNA. This study evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Erken, Robin, Loukachov, Vladimir V., de Niet, Annikki, Jansen, Louis, Stelma, Femke, Helder, Jeltje T., Peters, Martine W., Zaaijer, Hans L., Kootstra, Neeltje A., Willemse, Sophie B., Reesink, Hendrik W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168707/
https://www.ncbi.nlm.nih.gov/pubmed/35677522
http://dx.doi.org/10.1016/j.jceh.2021.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168707/
https://www.ncbi.nlm.nih.gov/pubmed/35677522
http://dx.doi.org/10.1016/j.jceh.2021.12.011

Ejemplares similares